If Amyloid Fails, We Are 15 Years Away from Having a Treatment Industry is in the business of developing products. For Alzheimer’s disease this has… Read more
Nsight Barbara Nelsen on the business of science.
Okay, @gdombal I will concede that Boston is the center of the universe for biopharma/biotech (for now), though I maintain Minnesota still retains its dominance in all… Read more
In our recent Minnesota Life Science Companies to Watch series, here and here we featured a number of up and coming companies including StemoniX. In… Read more
Just over 10 years ago, Shinya Yamanaka, a stem-cell scientist at Japan’s Kyoto University, discovered that mature adult cells could be reprogrammed back into an… Read more
Minnesota is known as a leader in medical device and healthcare and its presence in biopharma is growing. Adding to the list of exciting companies… Read more